Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.
Mol Biol Rep. 2013 Jul;40(7):4161-71. doi: 10.1007/s11033-013-2496-4. Epub 2013 May 8.
We reinvestigated rearrangements occurring in region q13 of chromosome 11 aiming to: (i) describe heterogeneity of the observed structural alterations, (ii) estimate amplicon size and (iii) identify of oncogenes involved in laryngeal cancer progression as potential targets for therapy. The study included 17 cell lines derived from laryngeal cancers and 34 specimens from primary laryngeal tumors. The region 11q13 was analyzed by fluorescence in situ hybridization (FISH), array comparative genomic hybridization (aCGH) and gene expression microarray. Next, quantitative real time PCR was used for chosen genes to confirm results from aCGH and gene expression microarray. The observed pattern of aberrations allows to distinguish three ways, in which gain and amplification involving 11q13 region may occur: formation of a homogeneously staining region; breakpoints in/near 11q13, which lead to the three to sevenfold increase of the copy number of 11q13 region; the presence of additional copies of the whole chromosome 11. The minimal altered region of gain and/or amplification was limited to ~1.8 Mb (chr.11:69,395,184-71,209,568) and comprised mostly 11q13.3 band which contain 12 genes. Five, out of these genes (CCND1, ORAOV1, FADD, PPFIA1, CTTN) had higher expression levels in comparison to healthy controls. Apart from CCND1 gene, which has an established role in pathogenesis of head and neck cancers, CTTN, ORAOV1 and FADD genes appear to be oncogene-candidates in laryngeal cancers, while a function of PPFIA1 requires further studies.
我们重新研究了发生在 11 号染色体 q13 区的重排,旨在:(i)描述观察到的结构改变的异质性,(ii)估计扩增子的大小,(iii)鉴定参与喉癌进展的癌基因,作为治疗的潜在靶点。该研究包括 17 株来自喉癌的细胞系和 34 例原发性喉肿瘤标本。11q13 区通过荧光原位杂交(FISH)、阵列比较基因组杂交(aCGH)和基因表达微阵列进行分析。然后,使用定量实时 PCR 对选定基因进行验证,以确认 aCGH 和基因表达微阵列的结果。观察到的畸变模式可以区分三种方式,11q13 区的增益和扩增可能通过以下方式发生:形成均质染色区;11q13 内/附近的断点,导致 11q13 区的拷贝数增加三到七倍;整个 11 号染色体的存在。增益和/或扩增的最小改变区域限制在约 1.8 Mb(chr.11:69,395,184-71,209,568),主要包含 11q13.3 带,其中包含 12 个基因。这些基因中有 5 个(CCND1、ORAOV1、FADD、PPFIA1、CTTN)的表达水平高于健康对照组。除了在头颈部癌症发病机制中具有既定作用的 CCND1 基因外,CTTN、ORAOV1 和 FADD 基因似乎是喉癌的癌基因候选基因,而 PPFIA1 基因的功能需要进一步研究。